为器官缺陷研究生成对照组:比较统计和基于人群药理动学的匹配方法的案例研究
Jessica Barry1, Sumit Bhatnagar1, Wei Liu1
1Clinical Pharmacology, AbbVie Inc, North Chicago, USA.
招募对照组进行器官功能障碍药物研究是很困难的. 统计匹配和药理动力学建模为创建虚拟对照组提供了可行的替代方案,提高了第一阶段研究的效率.
科学领域:
- 药理动力学 药理动力学
- 临床药理学 临床药理学
- 药物开发 药物开发
背景情况:
- 评估器官功能障碍中药物药理动学的第一阶段研究在招募人口统计学上匹配的对照组时面临挑战.
- 这种困难可能会阻碍对肝或功能障碍患者群体中药物暴露和安全概况的准确评估.
研究的目的:
- 评估在1期器官功能障碍研究中生成对照组的替代方法.
- 评估统计匹配和人口药动力学建模方法的可行性,以创建虚拟控制组.
主要方法:
- 来自upadacitinib和elagolix临床计划的第一阶段数据的回顾性分析.
- 评估统计匹配方法 (基因匹配与Mahalanobis距离, 3:1 k匹配) 和基于人口药理动力学 (PopPK) 模型的方法.
- 使用几何平均比率,比较器官损伤组和匹配/虚拟对照组之间的药物暴露 (Cmax,AUCinf).
主要成果:
- 统计匹配方法实现了适当的人口统计平衡,除了年龄,并将预测误差降到最低.
- 基于PopPK模型的方法产生了与研究中的对照结果相比较的结果.
- 替代方法和实验控制之间的几何平均比率的差异在两个案例研究中都处于可接受范围之内.
结论:
- 在第一阶段的器官功能障碍研究中,统计匹配和人口药理动力学建模都被证明是生成对照组的可行替代策略.
- 这些方法有可能克服招聘挑战,并促进在不同患者群体中评估药物药理动力学.
- 进一步验证可能会支持在临床药物开发中更广泛地采用这些方法.
更多相关视频
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
04:49Creating Matched In vivo/In vitro Patient-Derived Model Pairs of PDX and PDX-Derived Organoids for Cancer Pharmacology Research
Published on: May 5, 2021
相关概念视频
Analysis of Population Pharmacokinetic Data
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Dosage Regimens: Partial Pharmacokinetic Parameters
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Mechanistic Models: Compartment Models in Individual and Population Analysis
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
